New Glatt webinar: The impact of coronavirus on comparator sourcing in clinical trials
Monday, 18 October 2021 – 03:00 PM CEST | 09:00 AM EST
In this presentation there will be a critical review of the impact that the Coronavirus pandemic has had on comparator studies and to a lesser extent clinical trials in general.
We will review ongoing studies seeking to identify potential alternative treatments for the disease and the impact on drug availability pricing, timelines, the DCT paradigm shift and the impact on overall supply chain costs.
We will also review vaccination programs and all major non-Covid related influences on drug sourcing for trials over the last decade. There will be a final assessment of what challenges we may face as an industry moving forward and how we might achieve greater levels of patient centricity in the future.